Compare CADL & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | BALY |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | 55 | 11700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 739.2M | 711.1M |
| IPO Year | 2021 | 2019 |
| Metric | CADL | BALY |
|---|---|---|
| Price | $9.92 | $13.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $21.75 | $9.67 |
| AVG Volume (30 Days) | ★ 1.1M | 105.1K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | 8.37 |
| EPS | ★ N/A | N/A |
| Revenue | $125,000.00 | ★ $2,436,189,000.00 |
| Revenue This Year | N/A | $19.05 |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $8.44 |
| 52 Week High | $14.00 | $20.74 |
| Indicator | CADL | BALY |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 64.38 |
| Support Level | $9.18 | $12.59 |
| Resistance Level | $10.59 | $14.65 |
| Average True Range (ATR) | 0.56 | 0.83 |
| MACD | -0.12 | 0.09 |
| Stochastic Oscillator | 15.26 | 86.62 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.